EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients

Léa L Volmer, Cansu E Önder, Barbara Volz, Anjali R Singh, Sara Y Brucker iD, Tobias Engler iD, Andreas D Hartkopf iD, André Koch iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241813930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Léa L Volmer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Women's Health, University of Tübingen, 72076 Tübingen, Germany. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplastic Cells, Circulating, Bone Marrow, Cell Separation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Tübingen, German Cancer Aid, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disseminated tumor cells (DTCs) in the bone marrow (BM) of breast cancer (BC) patients are putative precursors of metastatic disease, and their presence is associated with an adverse clinical outcome. To achieve the personalization of therapy on a clinical routine level, the characterization of DTCs and in vitro drug testing on DTCs are of great interest. Therefore, biobanking methods, as well as novel approaches to DTC isolation, need to be developed. In this study, we established a protocol for the biobanking of BM samples and evaluated a microfluidic-based separation system (Parsortix®) for the enrichment of cryopreserved DTCs. We were able to successfully isolate viable DTCs after the prior cryopreservation of BM samples. We calculated a significant increase of up to 90-fold in harvested DTCs with the proposed method compared to the current standard techniques, opening up new analysis possibilities for DTCs. Our advanced method further presents options for 3D DTC cultures, enabling the individualized testing of targeted therapies for BC patients. In conclusion, we present a novel approach for DTC enrichment, with possibilities for future clinical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoplastic Cells, CirculatingBone MarrowCell SeparationMicrofluidicsHumansFemaleCryopreservation

Stichwörter der Autor:innen

Parsortixbreast cancerdisseminated tumor cells (DTCs)liquid biopsymicrofluidic cell separation

Autor:innen und Institutionen

  • Research Institute for Women's Health, University of Tübingen, 72076 Tübingen, Germany.
  • Department of Women's Health, University of Tübingen, 72076 Tübingen, Germany.

ORCID-Profile: Sara Y Brucker, Tobias Engler, Andreas D Hartkopf, André Koch

Förderung

  • Universitätsklinikum Tübingen
  • German Cancer Aid
  • Deutsche Forschungsgemeinschaft
  • Faculty of Medicine of the Eberhard Karls University Tübingen
  • German Research Foundation (DFG)

Zitieren

APA

Volmer, L. L., Önder, C. E., Volz, B., Singh, A. R., Brucker, S. Y., Engler, T., Hartkopf, A. D., & Koch, A. (2023). Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813930

Vancouver

Volmer LL, Önder CE, Volz B, Singh AR, Brucker SY, Engler T, et al. Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813930

BibTeX
@article{Volmer2023,
  author = {Volmer, Léa L and Önder, Cansu E and Volz, Barbara and Singh, Anjali R and Brucker, Sara Y and Engler, Tobias and Hartkopf, Andreas D and Koch, André},
  title = {Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241813930}
}
Kostenlos starten →